Health Check: The latest ASX biotech IPO is out of the blocks
Nexsen is off and running on its great ASX marathon. Pic: Getty Images Diagnostic play Nexsen surges 47% on its ASX debut, after a well-supported raising Audeara has entered the…
Health Check: Biotech investors reckon Trump’s tariffs may not be such a bitter pill
A better day so far, but if pain persists, keep blaming Donald Trump. Pic: Getty Images CSL shares lead the local biotech sector’s recovery Nyrada and Chimeric report their trials…
Best No Credit Check Business Financing Demand Rises as ROK Financial Expands Access to Small Business Loans in 2025
Section 1: Why Interest in Best No Credit Check Business Financing Is Surging in 2025 The conversation around business financing in 2025 is being shaped by several undeniable pressures. Rising…
Health Check: Medical device makers Trump drug developers in volatile US healthcare climate
Heart device makers are among the key medtech winners from the US healthcare turmoil. Pic via Getty Medical device makers – including ASX-listed heart plays – are the likely winners…